Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancers|April 25, 2020
Personalized Medicine: Recent Progress in Cancer TherapyValentina Gambardella, Noelia Tarazona, Juan Miguel Cejalvo, et al.
Plos One|October 19, 2012
Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancerTania Fleitas, Vicenta Martínez-Sales, Virtudes Vila, et al.
Cancer Treatment Reviews|August 26, 2025
Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of lifeMarco Airoldi, Susana Roselló, Noelia Tarazona, et al.
Current Opinion in Pharmacology|February 26, 2023
How organoids can improve personalized treatment in patients with gastro-esophageal tumorsManuel Cabeza-Segura, Blanca Garcia-Micò, Marcella La Noce, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 18, 2024
SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of gastric cancer (2023)Fernando Rivera, Federico Longo, Marta Martín Richard, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Foundational Models for Pathology and Endoscopy Images: Application for Gastric InflammationHamideh Kerdegari, Kyle Higgins, Dennis Veselkov, et al.
Oncotarget|September 4, 2015
Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancerMaider Ibarrola-Villava, Marta J Llorca-Cardeñosa, Noelia Tarazona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2018
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric CancerValentina Gambardella, Francisco Gimeno-Valiente, Noelia Tarazona, et al.
Anti-Cancer Drugs|November 18, 2015
Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastomaGaspar Reynés, Vicenta Martínez-Sales, Virtudes Vila, et al.
Oncotarget|May 6, 2016
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancersSarah Derks, Xiaoyun Liao, Anna M Chiaravalli, et al.
Pageof 5